triple antagonist glp-1 Agonist Peptides Explained: Retatrutide, GLP-3, and the Future of Metabolic Research Triple G Agonists – Retatrutide.

Semaglutide and tirzepatide were FDA-approved in 2021 as injectable treatments for weight loss, under the names Wegovy and Mounjaro

In STEP 4 (Rubino et al., JAMA 2021), all patients from week 0 to week 20 reached the full 2.4 mg weekly dose and lost an average of 10.6% of body weight in those 20 weeks

It helps in the activation of an enzyme (GSH transferase B) that plays an important role in detoxification (4)

Additionally, a study on young men in a 40% calorie deficit who ate 2.4 g of protein per kg of body weight while doing resistance training gained 1.2 kg of lean mass over four weeks while losing 4.8 kg of fat 7